<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00275990</url>
  </required_header>
  <id_info>
    <org_study_id>JETSTENT</org_study_id>
    <nct_id>NCT00275990</nct_id>
  </id_info>
  <brief_title>AngioJET Thrombectomy and STENTing for Treatment of Acute Myocardial Infarction</brief_title>
  <official_title>AngioJET Rheolytic Thrombectomy Before Direct Infarct Artery STENTing in Patients Undergoing Primary PCI for Acute Myocardial Infarction: [JETSTENT] Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether prompt removal of thrombus (blood clot)
      from a blocked coronary artery using the AngioJet rheolytic thrombectomy device will result
      in improved blood flow within the heart and a smaller final infarct size (reduced injury to
      the heart muscle).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Occlusive thrombosis triggered by a disrupted or eroded atherosclerotic plaque is the
      anatomic substrate of most acute myocardial infarctions (AMI). Macro- and microembolization
      of thrombus during percutaneous coronary intervention (PCI) in AMI is frequent and may result
      in obstruction of the microvessel network, and decreased efficacy of reperfusion and
      myocardial salvage. Direct stenting without predilation or postdilation is the most
      simplistic approach to the problem of embolization, and may decrease embolization and the
      incidence of the no-reflow phenomenon. Other approaches to the problem of microvessel
      embolization include percutaneous rheolytic thrombectomy (RT) with the AngioJet catheter
      before stent implantation. The objectives of the study are: to assess whether RT before
      direct infarct artery stenting results in improved reperfusion success in patients with acute
      ST-segment elevation myocardial infarction (STEMI) and angiographically evident thrombus; and
      to validate a technique for use of the AngioJet RT catheter in the treatment of STEMI.

      Comparisons: Treatment with AngioJet RT immediately before direct infarct artery stenting
      versus direct stenting alone, in patients with STEMI and angiographically visible thrombus
      presenting within 6 hours of symptom onset for primary PCI.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2005</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ST-segment resolution at 30 minutes post-PCI, assessed by 12-lead ECG</measure>
    <time_frame>30 minutes post procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Infarction size measured by technetium Tc 99m sestamibi imaging at 30 days</measure>
    <time_frame>30 days post-procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-procedure- TIMI flow, TIMI myocardial blush, and corrected TIMI frame count</measure>
    <time_frame>post-procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 days- Technetium Tc 99m sestamibi infarct size, MACE</measure>
    <time_frame>30 days post-procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 months- MACE</measure>
    <time_frame>6 months post-procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>12 months- MACE</measure>
    <time_frame>12 months post-procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">501</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>thrombectomy before stenting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>thrombectomy before stenting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>directing stenting alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>directing stenting alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rheolytic thrombectomy with direct stenting</intervention_name>
    <arm_group_label>thrombectomy before stenting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>direct stenting</intervention_name>
    <arm_group_label>directing stenting alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient age &gt; 18 years

          -  ST-segment elevation myocardial infarction

          -  Angiographically visible thrombus

          -  Presentation within 6 hours of symptom onset for primary percutaneous coronary
             intervention

          -  Patient, or relative or legal guardian,provides written informed consent

          -  Patient has no childbearing potential or is not pregnant

        Exclusion Criteria:

          -  Prior administration of thrombolysis for current MI

          -  Participation in another Study

          -  Major surgery within past 6 weeks

          -  History of stroke within 30 days, or any history of hemorrhagic stroke

          -  Severe hypertension (systolic BP &gt; 200 mm Hg or diastolic BP &gt; 110 mm Hg) not
             controlled on antihypertensive therapy

          -  Known neutropenia ( &lt;1000 neutrophils per mm3) or known severe thrombocytopenia (&lt;
             50,000 platelets per mm3)

          -  Known prior history of renal insufficiency

          -  Co-morbidities with expected survival &lt; 1 year

          -  Patient unwilling to receive blood products
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Antoniucci, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliero-Universitaria Careggi, Florence, ITALY</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Colombo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Raffaelle Hospital, Milan ITALY</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Careggi Hospital, Division of Cardiology</name>
      <address>
        <city>Florence</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Antoniucci D, Valenti R, Migliorini A, Parodi G, Memisha G, Santoro GM, Sciagr√† R. Comparison of rheolytic thrombectomy before direct infarct artery stenting versus direct stenting alone in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2004 Apr 15;93(8):1033-5.</citation>
    <PMID>15081450</PMID>
  </reference>
  <results_reference>
    <citation>Migliorini A, Stabile A, Rodriguez AE, Gandolfo C, Rodriguez Granillo AM, Valenti R, Parodi G, Neumann FJ, Colombo A, Antoniucci D; JETSTENT Trial Investigators. Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial. J Am Coll Cardiol. 2010 Oct 12;56(16):1298-306. doi: 10.1016/j.jacc.2010.06.011. Epub 2010 Aug 5.</citation>
    <PMID>20691553</PMID>
  </results_reference>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2006</study_first_submitted>
  <study_first_submitted_qc>January 11, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2006</study_first_posted>
  <last_update_submitted>October 8, 2014</last_update_submitted>
  <last_update_submitted_qc>October 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>coronary thrombectomy</keyword>
  <keyword>thrombectomy for acute myocardial infarction</keyword>
  <keyword>C14.280.647.500</keyword>
  <keyword>C14.907.553.355.500</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

